Baxalta Inc (BXLT) > Segments [Rocket]

Financials

Income Statement

Cash Flow Statement

Segments

Credit Analysis

Baxalta Inc (BXLT) > Segments

Inhibitor Therapies

Annual | Quarterly | TTM

In millions, except per share items	Dec-31-15	Dec-31-14	Dec-31-13
	10-K	10-K	10-K
Revenues	787	744	651
Revenue growth	5.8%	14.3%

Revenue Mix	12.8%	12.5%	11.7%

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy